M. Kiyik

Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study.

F. Koşar, A. Çakan, T. Goksel, 2007, Lung cancer.

A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non‐small cell lung cancer

H. Fırat, U. Yilmaz, E. Tabakoğlu, 2005, Respirology.

Brief Report: An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer

Tuan S. Nguyen, G. Scagliotti, S. Novello, 2016 .

Role of surgery in high-grade neuroendocrine tumors of the lung

S. Altın, N. Arda, N. Fener, 2019, Turk gogus kalp damar cerrahisi dergisi.

An Open‐Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC‐A12) as a First‐Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

Tuan S. Nguyen, G. Scagliotti, S. Novello, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.